Central Nervous System Alzheimer Disease

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Alzheimer Disease Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Alzheimer Disease Projects
--Barr Pharmaceuticals Inc
--Asubio Pharma Co., Ltd.
--Cortex Pharmaceuticals Inc
--Baxter International Inc
--Debiopharm Group
--DAIICHI SANKYO COMPANY, LIMITED
--Eli Lilly & Co
--Elan Corp Plc
--Forest Laboratories Inc
--ExonHit Therapeutics SA
--Hunter-Fleming Ltd
--GlaxoSmithKline plc
--Pfizer Inc
--Ono Pharmaceutical Co., Ltd.
--Sanofi-Aventis
--Ranbaxy Laboratories Ltd.
--TOYAMA CHEMICAL CO.,LTD.
--Teva Pharmaceutical Industries Ltd
--Wyeth
--TransTech Pharma, Inc.

--Top Companies in early stage Alzheimer Disease Projects
--Chiesi Farmaceutici S.p.A
--AstraZeneca Plc
--Elan Corp Plc
--D-Pharm Ltd
--ExonHit Therapeutics SA
--Evotec AG
--Mediolanum farmaceutici S.p.A.
--Intellect Neurosciences, Inc.
--Merck & Co Inc
--Memory Pharmaceuticals Corp
--Neuropharma, S.A.
--Mindset BioPharmaceuticals Ltd.
--Pfizer Inc
--Nymox Pharmaceutical Corporation
--Samaritan Pharmaceuticals Inc
--Roche Holdings Ltd
--TorreyPines Therapeutics, Inc.
--Sanofi-Aventis
--Wyeth
--TransTech Pharma, Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View